ABG Innovation Capital Partners III’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,747
Closed -$736K 2
2025
Q1
$736K Hold
36,747
91.94% 1
2024
Q4
$979K Hold
36,747
90.45% 1
2024
Q3
$1.05M Hold
36,747
93.29% 1
2024
Q2
$800K Buy
36,747
+3,121
+9% +$69.5K 93.07% 1
2024
Q1
$745K Sell
33,626
-3,121
-8% -$67.9K 89.54% 1
2023
Q4
$793K Buy
36,747
+3,121
+9% +$54.9K 88.14% 1
2023
Q3
$568K Hold
33,626
77.21% 1
2023
Q2
$461K Hold
33,626
63% 1
2023
Q1
$764K Hold
33,626
70.27% 1
2022
Q4
$792K Hold
33,626
60.43% 1
2022
Q3
$877K Hold
33,626
59.46% 1
2022
Q2
$738K Buy
+33,626
New +$781K 54.91% 1

Other funds holding CSTL